134 related articles for article (PubMed ID: 1688871)
1. Synthetic peptide homologous to the envelope proteins of retroviruses shares a cross-reacting epitope with the CD4 receptor.
Rothmann J; Hassan NF; Campbell DE; Kamani N; Douglas SD
J Clin Microbiol; 1990 Jan; 28(1):112-5. PubMed ID: 1688871
[TBL] [Abstract][Full Text] [Related]
2. A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.
Kleinerman ES; Lachman LB; Knowles RD; Snyderman R; Cianciolo GJ
J Immunol; 1987 Oct; 139(7):2329-37. PubMed ID: 2821111
[TBL] [Abstract][Full Text] [Related]
3. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.
Ruegg CL; Monell CR; Strand M
J Virol; 1989 Aug; 63(8):3250-6. PubMed ID: 2746730
[TBL] [Abstract][Full Text] [Related]
4. Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes.
Haraguchi S; Liu WT; Cianciolo GJ; Good RA; Day NK
Cell Immunol; 1992 May; 141(2):388-97. PubMed ID: 1576656
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
[TBL] [Abstract][Full Text] [Related]
7. Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.
Simons PJ; Oostendorp RA; Tas MP; Drexhage HA
Cancer Immunol Immunother; 1994 Mar; 38(3):178-84. PubMed ID: 8124686
[TBL] [Abstract][Full Text] [Related]
8. Effects of tumor growth on host defenses.
Cianciolo GJ; Snyderman R
Cancer Metastasis Rev; 1986; 5(1):15-27. PubMed ID: 3524888
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136
[TBL] [Abstract][Full Text] [Related]
10. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.
Javaherian K; Langlois AJ; Montefiori DC; Kent KA; Ryan KA; Wyman PD; Stott J; Bolognesi DP; Murphey-Corb M; Larosa GJ
J Virol; 1994 Apr; 68(4):2624-31. PubMed ID: 7511176
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein.
Haraguchi S; Good RA; James-Yarish M; Cianciolo GJ; Day NK
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3611-5. PubMed ID: 7724606
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of murine cytotoxic T lymphocyte activity by a synthetic retroviral peptide and abrogation of this activity by IL.
Ogasawara M; Haraguchi S; Cianciolo GJ; Mitani M; Good RA; Day NK
J Immunol; 1990 Jul; 145(2):456-62. PubMed ID: 2195116
[TBL] [Abstract][Full Text] [Related]
13. A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815.
Belladonna ML; Fioretti MC; Bianchi R; Puccetti P; Grohmann U
Int J Immunopharmacol; 1996 Oct; 18(10):563-76. PubMed ID: 9080250
[TBL] [Abstract][Full Text] [Related]
14. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
Falconar AK
Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
[TBL] [Abstract][Full Text] [Related]
15. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.
Haraguchi S; Good RA; James-Yarish M; Cianciolo GJ; Day NK
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5568-71. PubMed ID: 7777549
[TBL] [Abstract][Full Text] [Related]
16. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
Klasse PJ; Pipkorn R; Blomberg J
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
[TBL] [Abstract][Full Text] [Related]
17. Characterization of T- and B-cell epitopes of a simian retrovirus (SRV-2) envelope protein.
Malley A; Werner L; Benjamini E; Leung CY; Torres J; Pangares N; Shiigi S; Axthelm M
J Med Primatol; 1991 Jun; 20(4):177-81. PubMed ID: 1719205
[TBL] [Abstract][Full Text] [Related]
18. Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.
Wallace LE; Wright J; Ulaeto DO; Morgan AJ; Rickinson AB
J Virol; 1991 Jul; 65(7):3821-8. PubMed ID: 1710291
[TBL] [Abstract][Full Text] [Related]
19. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptides of envelope proteins of two different strains of simian AIDS retrovirus (SRV-1 and SRV-2) represent unique antigenic determinants for serum neutralizing antibodies.
Werner LL; Malley A; Torres JV; Leung CY; Kwang HS; Benjamini E
Mol Immunol; 1990 Nov; 27(11):1103-11. PubMed ID: 1701027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
